American Marconi Wireless News

NYSE - LSE

RBGPF	100%	68	$
SCS	3.18%	11.32	$
NGG	0.26%	65.78	$
CMSD	0.04%	22.82	$
BCC	0.83%	98.91	$
AZN	-1.24%	72.6	$
CMSC	0.18%	22.44	$
RIO	0.25%	60.23	$
BTI	-0.66%	41.1	$
GSK	-2.3%	37.87	$
JRI	0.31%	12.98	$
RELX	0.51%	50.67	$
BCE	-0.79%	22.78	$
RYCEF	3.48%	10.05	$
VOD	-1.08%	9.27	$
BP	0.06%	33.81	$

Featured

Trump faces first electoral setback after Wisconsin Supreme Court vote

Donald Trump's second presidency was dealt a spinning blow by voters in Wisconsin Tuesday as they elected a liberal judge to the state's Supreme Court, despite his powerful advisor Elon Musk pouring millions into the race to sway the polls.

Myanmar quake victim rescued after 5 days as aid calls grow

Rescuers on Wednesday pulled a man alive from the rubble five days after Myanmar's devastating earthquake, as calls grew for the junta to allow more aid in and halt attacks on rebels.

Last news

Motorcyclist killed by giant Seoul sinkhole

One person has been killed after a massive sinkhole opened up in Seoul, the fire department said Tuesday, with harrowing video footage showing the moment his vehicle was swallowed by the hole.

South Korea struggles to contain deadly wildfires

Deadly wildfires in South Korea worsened overnight, officials said Tuesday, as dry, windy weather hampers efforts to contain one of the country's worst-ever fire outbreaks.

Dozens of fires rage in southern Chile

Dozens of fires fueled by strong winds raged across southern Chile Monday, destroying thousands of hectares of forest and farmland and damaging several homes, according to authorities.

Innovation Beverage Group's Bitters Captures 45% Market Share in Australia Driven by 2024 Sales Growth

Australia is the world's second largest bitters market, behind only the U.S.

CBD Life Sciences Inc. (CBDL) Gears Up for Cave Creek Bike Week 2025

CBDL Targets a Multi-Million Dollar Market as Tens of Thousands of Attendees Converge for Arizona's Hottest Motorcycle Event

CNS Pharmaceuticals Announces Primary Analysis of Berubicin in Second Line Treatment of Glioblastoma Multiforme

Berubicin showed clinically relevant outcomes comparable to Lomustine across multiple endpoints, but not a statistically significant difference in overall survival, the primary endpoint.The safety profile continues to be favorable, including the absence of anthracycline related cardiotoxicity.Analysis of outcomes are ongoing, including advanced imaging review, PK, and clinical endpoints.The company also continues development of a novel taxane, TPI 287, with published clinical efficacy data in Glioblastoma Multiforme.

Xebra Brands Evaluates Strategic Opportunities Following Award of Dutch Cannabis License

VANCOUVER, BC / ACCESS Newswire / March 25, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a trailblazer in the Mexican cannabis sector and the sole company legally permitted to cultivate, manufacture, operate, and sell cannabis (-1% THC) in Mexico, is excited to announce, that subsequent to the issuance of a highly selective Dutch cannabis cultivation license for scientific research on June 13, 2024, Xebra Brands Europe B.V., a wholly owned subsidiary of Xebra Brands Ltd., is pursuing a number of strategic opportunities enabled by this regulatory breakthrough.

Celebrating National Nutrition Month: FriskaAi Unveils Free Version of its Innovative Nutrition Tool

ARLINGTON, VA / ACCESS Newswire / March 25, 2025 / FriskaAi, a groundbreaking healthcare platform that leverages advanced AI and mobile technology to empower individuals to take control of their health journey in partnership with their physician, has launched a slimmed-down version of its Friska NutriAi platform revolutionizing nutrition and wellness through the power of AI. Available at no cost to consumers, this special version of Friska's nutrition management tool provides personalized dietary guidance to enhance well-being, manage chronic diseases, and optimize health outcomes.

Exousia Pro Officially Announces the Production of Plant-Based Exosomes Has Begun

Exousia Pro will be sending out samples to clients expected to place orders

MAGIC Nashville Returns with Two-Days of Networking, Entertainment and Spotlighting Local Fashion Collections

NASHVILLE, TN / ACCESS Newswire / March 25, 2025 / MAGIC Nashville is set to bring the heart and soul of Nashville to life with a dynamic showcase of local and national brands across apparel, accessories and footwear to the Music City Center April 16-17. The premier fashion event will blend high-energy shopping, networking and entertainment, offering attendees an exclusive first look at seasonal collections and local brands.

TPT Global Tech Successfully Broadcast its Frist Professional Indoor Soccer Match On VuMe Live

San Diego Sockers Edge Out Empire Strykers 9–8 in Thrilling MASL Showdown Broadcast Live on VuMe Super App

Tenon Medical, Inc. Announces a Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

LOS GATOS, CA / ACCESS Newswire / March 25, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced it has entered into a securities purchase agreement with a single healthcare focused institutional investor for the issuance and sale of 733,500 shares of its common stock (or common stock equivalents in lieu thereof) in a registered direct offering priced at-the-market under Nasdaq rules at a purchase price of $2.00.

Bausch Health Announces Pricing of Upsized Private Offering of Senior Secured Notes

LAVAL, QC / ACCESS Newswire / March 25, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health") today announced that it has priced its previously announced offering (the "Offering") of $4.4 billion aggregate principal amount of 10.000% senior secured notes due 2032 (the "Notes") through its indirect wholly-owned subsidiary, 1261229 B.C. Ltd. (the "Issuer"), a company incorporated under the laws of British Columbia, Canada (the "Issuer") that, at the closing of the transactions will be a non-guarantor restricted subsidiary under the indentures that govern the Company's existing senior notes. The Offering was upsized from an initial offering size of $4.0 billion aggregate principal amount. The Offering is expected to close on April 8, 2025, subject to the satisfaction of customary closing conditions.

Onco-Innovations Extends Marketing Program

VANCOUVER, BC / ACCESS Newswire / March 25, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") announces that it has extended the term of its engagement with MCS Market Communication Service GmbH (business address: Rheinpromenade 13, 40789 Monheim am Rhein, Nordrhein-Westfalen, Deutschland, email: [email protected]; telephone: +491772481220; and website: www.mcsmarket.de) ("MCS") for the continued provision of a range of online marketing services, including campaign creation, production of marketing materials, as well as research and analytics (the "Services"). The Services are expected to run until May 31, 2025, or until budget exhaustion. The Company has paid MCS CAD 600,000 for the extended term of Services, and no securities have been provided to MCS or its principals as compensation. The Services will be executed via digital channels, including Google Ads and native advertising.

William Curtis Chairman and CEO of Beargrill.com and Josephine Gothong President are Presently Presenting

CineCity Studios Chicago Illinois

Tenon Medical, Inc. Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

LOS GATOS, CA / ACCESS Newswire / March 25, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced it has entered into a securities purchase agreement with a single healthcare focused institutional investor for the issuance and sale of 1,271,500 shares of its common stock (or common stock equivalents in lieu thereof) in a registered direct offering priced at-the-market under Nasdaq rules at a purchase price of $2.00.

Protesters hit Istanbul streets again over Erdogan rival's arrest

Vast crowds of students surged onto Istanbul's streets Monday in the latest protest over the arrest and jailing of Istanbul's opposition mayor that has sparked Turkey's worst unrest in years.

Mexican cartel recruits allegedly killed for resisting training

A Mexican drug cartel allegedly tortured and killed recruits who refused to cooperate or tried to flee a training camp where bones and clothing were found, the government said Monday.

Police question French rapper over drug baron's prison break

Police interrogated on Monday well-known French rapper Koba LaD over the deadly escape from prison of a suspected drugs boss last year, sources told AFP.

S. Korea authorities deploy choppers, troops to battle wildfire

South Korean authorities said Monday they would deploy dozens of helicopters and thousands of firefighters and soldiers as they struggle to control multiple wildfires in the southeast, which have been burning for days.

Trump's US migrant hunt spares no one from deportation

Franco Caraballo was arrested while at a US immigration center for an appointment. Shirly Guardado was detained while at work. Camila Munoz was taken into custody on her way home from her honeymoon.

Hemogenyx Pharmaceuticals PLC Announces First Patient Safety

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU WHICH IS PART OF DOMESTIC UK LAW PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIIONS (SI 2019/310) ("UK MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION (AS DEFINED IN UK MAR) IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.24 March 2025Hemogenyx Pharmaceuticals plc("Hemogenyx Pharmaceuticals" or the "Company")First Patient Treated with HG-CT-1 CAR-T Therapy Passes Initial Safety Tests

DEA Marijuana Policy Reform - Matthew Strait you're Fired - Highlighted in Heated Oversight Congressional Hearing

"This is insanity," declares Duane Boise, CEO of MMJ International Holdings, echoing the sentiments of lawmakers and researchers alike. The 2020 House Oversight Committee hearing, and ongoing developments, have laid bare the Drug Enforcement Administration's (DEA) persistent obstruction of legitimate cannabis research, a battle MMJ has been fighting since their 2018 application. Despite bipartisan congressional outrage, as highlighted by Representative Earl "Buddy" Carter's scathing critique of the DEA's "epitome of ineptitude," and the agency's own hollow defenses, the DEA, represented by figures like Matthew Strait and Thomas Prevoznik, continues to delay and deny, hindering vital medical advancements. Boise's lawsuit against the DEA underscores the urgent need for reform, as the agency's actions not only impede scientific progress but also deny patients access to potentially life-changing treatments, a situation that demands immediate structural changes in federal cannabis policy.

MIRA Pharmaceuticals Signs Binding Letter of Intent to Acquire SKNY Pharmaceuticals, Securing a $5 Million Capital Infusion to Advance Weight Loss and Smoking Cessation Drug Development

Strategic acquisition expands MIRA's pipeline with SKNY-1, a next-generation oral therapeutic targeting the two leading causes of preventable death-obesity and smoking.

Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada

FORT LAUDERDALE, FL / ACCESS Newswire / March 24, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that is has signed a strategic agreement granting it the rights to market two new generic antibiotics in Canada. The Company anticipates launching these new products through its wholly-owned Canadian subsidiary, Nora Pharma, in the next six to nine months following regulatory approval.

ARC Facilities Unveils Partner Program to Expand Facility Management Industry Reach

Empowering partners with mobile-first solutions to accelerate access to critical building information, enhance operations, and unlock new revenue opportunities - Learn more at NFMT Baltimore.

CIO Celebrates Innovations in Business Technology with 2025 CIO 100 & Hall of Fame Awards

Winners and the industry at large will gather at the CIO 100 Symposium & Awards this August in Scottsdale, AZ

DEXIS to Showcase Cutting-Edge Innovations at IDS 2025

The company will showcase new technologies within the DEXIS digital ecosystem, an AI-powered platform that connects each step of the digital workflow, from diagnosis to delivery. The ecosystem combines AI, 2D & 3D imaging, intraoral scanning, diagnostics, and treatment planning to create one integrated solution that streamlines processes and boosts productivity.

Desert Oasis Healthcare Celebrates Doctor’s Day, Honoring Exceptional Care and Dedication

Recognizing the Heart of Healthcare: Desert Oasis Celebrates Physicians' Commitment to Excellence and Patient Care

New to The Street’s FOX Business Show #638 Spotlights Visionary CEOs and Breakthrough Innovations Across Health, AI, and Insurance Featuring BioVie CEO Cuong Do, Roadzen CEO Rohan Malhotra, Lou Basenese’s The Big Skinny on eXoZymes, and Banzai CEO Joe Davy

Sponsored by The Sustainable Green Team and Featuring an Exclusive Interview with Former Shark Kevin Harrington

Tenon Medical(R) Announces FDA Clearance of Catamaran(R) SI Joint Fusion System for New Indication to Augment Spinal Fusion

~ Achieves Significant Milestone with Expanded Use Indication, Opens Sizable New SI Market Opportunity ~

Ainos to Participate in Fireside Chat with Water Tower Research on April 8, 2025

SAN DIEGO, CALIFORNIA / ACCESS Newswire / March 24, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent digitization, today announced that it will participate in a fireside chat with Do Kim, senior research analyst of Water Tower Research ("WTR") and John Roy, managing director of WTR on Tuesday, April 8, 2025, at 10:00 a.m. ET.

American Marconi Wireless News - Boulevard (English)